One year update on the COVID-19 pandemic: Where are we now?
SK Mishra, T Tripathi - Acta tropica, 2021 - Elsevier
We are living through an unprecedented crisis with the rapid spread of the new coronavirus
disease (COVID-19) worldwide within a short time. The timely availability of thousands of …
disease (COVID-19) worldwide within a short time. The timely availability of thousands of …
Review on 3D printing: Fight against COVID-19
The outbreak of coronavirus disease in 2019 (COVID-19) caused by the SARS-CoV-2 virus
and its pandemic effects have created a demand for essential medical equipment. To date …
and its pandemic effects have created a demand for essential medical equipment. To date …
[HTML][HTML] A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries
Background With the rapid development of the genomic sequence data for the Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants Delta (B. 1.617. 2) and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants Delta (B. 1.617. 2) and …
Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS …
The scientific community is continuously working to discover drug candidates against
potential targets of SARS-CoV-2, but effective treatment has not been discovered yet. The …
potential targets of SARS-CoV-2, but effective treatment has not been discovered yet. The …
[HTML][HTML] Mutations of Omicron variant at the interface of the receptor domain motif and human angiotensin-converting enzyme-2
The most recent Omicron variant of SARS-CoV-2 has caused global concern and anxiety.
The only thing certain about this strain, with a large number of mutations in the spike protein …
The only thing certain about this strain, with a large number of mutations in the spike protein …
Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study
Abstract Papain-Like Protease (PLpro) is a key protein for SARS-CoV-2 viral replication
which is the cause of the emerging COVID-19 pandemic. Targeting PLpro can suppress viral …
which is the cause of the emerging COVID-19 pandemic. Targeting PLpro can suppress viral …
In silico approaches for drug repurposing for SARS-CoV-2 infection
SA Kulkarni, K Ingale - 2022 - books.rsc.org
The coronavirus disease 2019 (COVID-19) pandemic that the world is facing currently is a
rare and once-in-a-lifetime situation. The fast spread of the virus worldwise has been …
rare and once-in-a-lifetime situation. The fast spread of the virus worldwise has been …
[PDF][PDF] Docking of fda approved drugs targeting nsp-16, n-protein and main protease of sars-cov-2 as dual inhibitors
At present world is lurching under the spread of new SARS-CoV-2 infection. The treatment is
still elusive despite the relentless effort by the scientists against various viral structures …
still elusive despite the relentless effort by the scientists against various viral structures …
[HTML][HTML] SARS-CoV-2 spike protein-, main protease-and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: an in silico …
Background The anti-COVID-19 potential of phytochemicals was investigated in numerous
studies, but efficacy of peptides released by seed proteins upon gastrointestinal (GI) …
studies, but efficacy of peptides released by seed proteins upon gastrointestinal (GI) …
[HTML][HTML] What binds cationic photosensitizers better: Brownian dynamics reveals key interaction sites on spike proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2
V Fedorov, E Kholina, S Khruschev, I Kovalenko… - Viruses, 2021 - mdpi.com
We compared the electrostatic properties of the spike proteins (S-proteins) of three
coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2, and their interactions with …
coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2, and their interactions with …